The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Risk factors for prostate cancer incidence and progression in the health professionals follow‐up study
Open accessAbstract
Risk factors for prostate cancer could differ for various sub‐groups, such as for “aggressive” and “non‐aggressive” cancers or by grade or stage. Determinants of mortality could differ from those for incidence. Using data from the Health Professionals Follow‐Up Study, we re‐examined 10 factors (cigarette smoking history, physical activity, BMI, family history of prostate cancer, race, height, total energy consumption, and intakes of calcium, tomato sauce and α‐linolenic acid) using multivariable Cox regression in relation to multiple subcategories for prostate cancer risk. These were factors that we previously found to be predictors of prostate cancer incidence or advanced prostate cancer in this cohort, and that have some support in the literature. In this analysis, only 4 factors had a clear statistically significant association with overall incident prostate cancer: African–American race, positive family history, higher tomato sauce intake (inversely) and α‐linolenic acid intake. In contrast, for fatal prostate cancer, recent smoking history, taller height, higher BMI, family history, and high intakes of total energy, calcium and α‐linolenic acid were associated with a statistically significant increased risk. Higher vigorous physical activity level was associated with lower risk. In relation to these risk factors, advanced stage at diagnosis was a good surrogate for fatal prostate cancer, but high‐grade (Gleason ≥ 7 or Gleason ≥ 8) was not. Only for high calcium intake was there a close correspondence for associations among high‐grade cancer, advanced and fatal prostate cancer. Tomato sauce (inversely) and α‐linolenic acid (positively) intakes were strong predictors of advanced cancer among those with low‐grade cancers at diagnosis. Although the proportion of advanced stage cancers was much lower after PSA screening began, risk factors for advanced stage prostate cancers were similar in the pre‐PSA and PSA era. The complexity of the clinical and pathologic manifestations of prostate cancer must be considered in the design and interpretation of studies. © 2007 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer Incidence in Five Continents
(1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,501
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
The Influence of Finasteride on the Development of Prostate Cancer
Thompson, I. M., Goodman, P. J., Tangen, C. M., Lucia, M. S., Miller, G. J., Ford, L. G., Lieber, M. M., Cespedes, R. D., Atkins, J. N., Lippman, S. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030660 · Cited by 2,518
Rimm, E. B., Giovannucci, E. L., Stampfer, M. J., Colditz, G. A., Litin, L. B., & Willett, W. C. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116211 · Cited by 2,104
Self-citationSathianathen, N. (2021) · 50 Studies Every Urologist Should Know · doi:10.1093/med/9780190655341.003.0002 · Cited by 2,080
Intake of Carotenoids and Retino in Relation to Risk of Prostate Cancer
Giovannucci, E., Ascherio, A., Rimm, E. B., Stampfer, M. J., Colditz, G. A., & Willett, W. C. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.23.1767 · Cited by 1,320
Self-citation(1968) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/40.1.43 · Cited by 1,108
Hu, F. B., Stampfer, M. J., Rimm, E., Ascherio, A., Rosner, B. A., Spiegelman, D., & Willett, W. C. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009849 · Cited by 1,085
Self-citationFeskanich, D., Rimm, E. B., Giovannucci, E. L., Colditz, G. A., Stampfer, M. J., Litin, L. B., & Willett, W. C. (1993) · Journal of the American Dietetic Association · doi:10.1016/0002-8223(93)91754-e · Cited by 1,070
Self-citationValidity of Self-Reported Waist and Hip Circumferences in Men and Women
Rimm, E. B., Stampfer, M. J., Colditz, G. A., Chute, C. G., Litin, L. B., & Willett, W. C. (1990) · Epidemiology · doi:10.1097/00001648-199011000-00009 · Cited by 1,015
Self-citation
Cited by
Epidemiology of Prostate Cancer
Rawla, P. (2019) · World Journal of Oncology · doi:10.14740/wjon1191 · Cited by 2,776
Race, socioeconomic status, and health: Complexities, ongoing challenges, and research opportunities
Williams, D. R., Mohammed, S. A., Leavell, J., & Collins, C. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05339.x · Cited by 1,458
The Epidemiology of Prostate Cancer
Pernar, C. H., Ebot, E. M., Wilson, K. M., & Mucci, L. A. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a030361 · Cited by 773
Kenfield, S. A., Stampfer, M. J., Giovannucci, E., & Chan, J. M. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.5226 · Cited by 601
Self-citationCao, Y., & Ma, J. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0229 · Cited by 485
Ma, J., Li, H., Giovannucci, E., Mucci, L., Qiu, W., Nguyen, P. L., Gaziano, J. M., Pollak, M., & Stampfer, M. J. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70235-3 · Cited by 421
Self-citationTowards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids
Harris, W. S., Mozaffarian, D., Lefevre, M., Toner, C. D., Colombo, J., Cunnane, S. C., Holden, J. M., Klurfeld, D. M., Morris, M. C., & Whelan, J. (2009) · The Journal of Nutrition · doi:10.3945/jn.108.101329 · Cited by 356
Lemaître, G., Martí, R., Freixenet, J., Vilanova, J. C., Walker, P. M., & Meriaudeau, F. (2015) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2015.02.009 · Cited by 348
Aune, D., Navarro Rosenblatt, D. A., Chan, D. S., Vieira, A. R., Vieira, R., Greenwood, D. C., Vatten, L. J., & Norat, T. (2015) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.067157 · Cited by 314
Smoking as a Risk Factor for Prostate Cancer: A Meta-Analysis of 24 Prospective Cohort Studies
Huncharek, M., Haddock, K. S., Reid, R., & Kupelnick, B. (2010) · American Journal of Public Health · doi:10.2105/ajph.2008.150508 · Cited by 312
Risk factors for the onset of prostatic cancer: age, location, and behavioral correlates
Leitzmann, M., & Rohrmann, S. (2012) · Clinical Epidemiology · doi:10.2147/clep.s16747 · Cited by 304
Dietary fats and coronary heart disease
Willett, W. C. (2012) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2012.02553.x · Cited by 297
Self-citationRichman, E. L., Kenfield, S. A., Stampfer, M. J., Paciorek, A., Carroll, P. R., & Chan, J. M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3932 · Cited by 297
Self-citationThe Role of Obesity in Cancer Survival and Recurrence
Demark-Wahnefried, W., Platz, E. A., Ligibel, J. A., Blair, C. K., Courneya, K. S., Meyerhardt, J. A., Ganz, P. A., Rock, C. L., Schmitz, K. H., Wadden, T., et al. (2012) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0485 · Cited by 290
Self-citationDiscacciati, A., Orsini, N., & Wolk, A. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr603 · Cited by 278
Smoking and Prostate Cancer Survival and Recurrence
Kenfield, S. A. (2011) · JAMA · doi:10.1001/jama.2011.879 · Cited by 275
Garcia, L., Pearce, M., Abbas, A., Mok, A., Strain, T., Ali, S., Crippa, A., Dempsey, P. C., Golubic, R., Kelly, P., et al. (2023) · British Journal of Sports Medicine · doi:10.1136/bjsports-2022-105669 · Cited by 273
Jahn, J. L., Giovannucci, E. L., & Stampfer, M. J. (2015) · International Journal of Cancer · doi:10.1002/ijc.29408 · Cited by 268
Self-citationA prospective investigation of PTEN loss and ERG expression in lethal prostate cancer
Ahearn, T. U., Pettersson, A., Ebot, E. M., Gerke, T., Graff, R. E., Morais, C. L., Hicks, J. L., Wilson, K. M., Rider, J. R., Sesso, H. D., et al. (2015) · Journal of the National Cancer Institute · doi:10.1093/jnci/djv346 · Cited by 186
Self-citationLabbé, D. P., Zadra, G., Yang, M., Reyes, J. M., Lin, C. Y., Cacciatore, S., Ebot, E. M., Creech, A. L., Giunchi, F., Fiorentino, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12298-z · Cited by 174
Mazzu, Y. Z., Armenia, J., Chakraborty, G., Yoshikawa, Y., Coggins, S. A., Nandakumar, S., Gerke, T. A., Pomerantz, M. M., Qiu, X., Zhao, H., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-4046 · Cited by 156
Mammary tumor growth and pulmonary metastasis are enhanced in a hyperlipidemic mouse model
Alikhani, N., Ferguson, R. D., Novosyadlyy, R., Gallagher, E. J., Scheinman, E. J., Yakar, S., & LeRoith, D. (2013) · Oncogene · doi:10.1038/onc.2012.113 · Cited by 146
Developing High-Quality Cancer Rehabilitation Programs: A Timely Need
Alfano, C. M., Cheville, A. L., & Mustian, K. (2016) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_156164 · Cited by 107
Impact of obesity upon prostate cancer-associated mortality: A meta-analysis of 17 cohort studies
ZHANG, X., ZHOU, G., SUN, B., ZHAO, G., LIU, D., SUN, J., LIU, C., & GUO, H. (2015) · Oncology Letters · doi:10.3892/ol.2014.2841 · Cited by 91
Choline intake and risk of lethal prostate cancer: incidence and survival
Richman, E. L., Kenfield, S. A., Stampfer, M. J., Giovannucci, E. L., Zeisel, S. H., Willett, W. C., & Chan, J. M. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.039784 · Cited by 75
Self-citationRole of chemokines and chemokine receptors in prostate cancer development and progression.
Singh, R. K., Sudhakar, A., & Lokeshwar, B. L. (2010) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.1000030 · Cited by 45
Mitchell, J., Camacho, N., Shea, P., Stopsack, K. H., Joseph, V., Burren, O. S., Dhindsa, R. S., Nag, A., Berchuck, J. E., O’Neill, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56944-1 · Cited by 19
Fitzpatrick, K. C. (2011) · Omega-3 Oils · doi:10.1016/b978-1-893997-82-0.50013-x · Cited by 8
Metadata
- Authors
- Giovannucci, E., Liu, Y., Platz, E. A., Stampfer, M. J., & Willett, W. C.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2007-04-20
- Volume
- 121
- Issue
- 7
- Pages
- 1571-1578
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W1985298987
- Cited by
- 522
- References
- 40
- FWCI
- 29.68
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.